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Background: Judgement and reaction times during complex tasks like driving may be 
impaired in older adults with chronic heart failure (HF).  
Objectives: This study sought to report the driving habits and reaction times of older patients 
with HF in a specially designed urban driving simulation.  
Methods: We conducted a prospective observational study in HF patients and controls. 
Patients in both groups underwent cognitive testing and screening for depression. Current 
drivers undertook questionnaire regarding driving habits followed by an urban road driving 
simulation consisting of three laps. Five separate hazards appeared in the third lap without 
warning. Reaction times and stopping distances to the hazards were calculated.  
Results: Of 247 patients with HF approached for the study, 124 had already voluntarily 
stopped driving due to HF (n=92) or other medical conditions (n=32), 60 had never had a 
license, and 32 declined to participate. Of the 74 controls approached, 1 was not currently 
driving due to a medical condition, and 46 declined to participate. Patients in both groups had 
similar levels of cognitive function, mood and driving habits. 30 patients with HF [mean (SD) 
age 74 (±5) years, median (IQR) NT-proBNP 1510 (546-3084) pg/L] and 26 controls [mean 
age 73 (±5) years, median NT-proBNP 135 (73-182) pg/L] completed the simulation. During 
lap 3, there was no difference in the driving speed between patients (mean 22.0 SD 4.5 mph) 
and controls (mean 21.7 SD3.3 mph; p=0.80). Patients had longer reaction times [median 
1.10 (IQR 0.98-1.30) seconds) than controls [median 0.96 (IQR 0.83-1.10) seconds, p=0.02], 
but there was no difference in stopping distances [patients: median 43.9 (IQR 32.2- 49.5) 
metres; controls: median 38.1 (IQR 32.3-48.8) metres, p=0.31)].  




Conclusions: Many older adults with HF no longer drive. Those who continue to drive 
appear safe to drive on simulated urban roads.   
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Many cardiac illnesses predispose patients to cerebrovascular disease, potentially impairing 
their driving ability, making it less safe for the patient and other road users. Cognitive 
impairment is common in older people and is strongly associated with chronic heart failure 
(HF),[1] which may impair the ability of patients with HF to drive safely.[2] Although 
current European and American guidelines emphasise the importance of comorbidities that 
influence activities of daily living, they do not recommend restricting driving in patients with 
HF without severe symptoms at rest (New York Heart Association, NYHA class IV).[3,4]  
In the United Kingdom (UK), the Driver & Vehicle Licensing Agency (DVLA) provides 
guidance on assessing fitness to drive in those with cardiovascular disease.[5] Only patients 
with NYHA class IV symptoms and those with devices in situ are obliged to stop driving. 
Temporary restrictions apply to those with life-threatening arrhythmias.  
There is a literature on driving safety in patient receiving palliative care,[6] but very little is 
known about patients with HF. In particular, no studies have investigated reaction times to 
unexpected hazards, an important measure of safe driving ability and a routine part of the 
UK‟s driving licensing examinations.   
We therefore investigated the driving habits and reaction times of patients with HF in 
comparison with age-matched controls using a previously validated driving habits 
questionnaire and a specially designed driving simulation. We hypothesised that patients with 
HF will have longer reaction times and stopping distances to on-road driving hazards, 
compared to controls.   







This is a prospective cohort study conducted in an outpatient setting in Hull, UK between 
May and August 2017. We enrolled patients with and without HF who were at least 60 years 
old within 6 months of screening. Control subjects had to fulfil the following criteria:1) no 
previous or current symptoms or signs of HF; 2) left ventricular function better than, or equal 
to, mild-moderate systolic dysfunction or LVEF>45% on echocardiography. Many 
hadclinical risk factors for developing HF, including coronary artery disease, diabetes 
mellitus or hypertension because they are highly prevalent in the older population.  From an 
initial survey population of 247 patients with HF, 31 took part in the driving simulation. We 
recruited 27 controls of similar age. We wanted patients to reflect those who were actively 
driving and therefore only included stable patients (no admission to hospital within the last 
month) with a valid UK driving license, who drove at least once a week. None had 
experience with commercial driving video games or simulations.  
The North East Tyne & Wear South Research Ethics Committee approved the study protocol 
(REC Reference17/NE/0021). This study complies with the Declaration of Helsinki, and all 
patients gave signed consent. Two investigators (DP and CW) recruited and studied each 
participant.  
 
Patient and public involvement statement  
Patients helped to write a plan language summary and design a leaflet for dissemination to 
their peers and patient groups. Patients were also involved in the design of the driving 
simulation to ensure that it reflected the local environment. Control subjects had previously 
agreed to be approached for research studies. It was difficult to involve patients in other 








All subjects were asked to complete the Patient Health Questionnaire-9 (PHQ-9) and 
Montreal Cognitive Assessment (MoCA) since major depression or previously undiagnosed 
severe cognitive impairment may have an impact on driving ability.[7,8] Patients‟ driving 
habits were then assessed with the Driving Habits Questionnaire (DHQ) before the driving 
simulation.  
a) Patient Health Questionnaire – 9 (PHQ-9) 
PHQ-9 is a self-administered survey used to identify depression.[9] Patients indicate the 
frequency with which they experienced the thoughts conveyed by nine statements. Each 
statement forms a component of the diagnostic criteria for depression, as defined by the 
Diagnostic and Statistical Manual of Mental Disorders. The answers are scored as 0= not at 
all, 1 = several days, 2 = more than half of days, 3 = nearly every day. A score of 5-9 is 
suggestive of mild depression; a score of ≥10 is diagnostic of major depression.[10]  
b) Montreal Cognitive Assessment (MoCA) 
The MoCA is a interviewer-administered questionnaire that assesses multiple areas of 
cognitive function. The MoCA has higher sensitivity in detecting cognitive deficits, including 
mild cognitive impairment, in comparison to other screens, such as the mini-mental state 
examination.[11] The original form of the MoCA (Version 7.1) was used.[12] Scores range 
from 0 to 30 points, with a lower score reflecting greater cognitive impairment. A score of 




18-26 indicates mild cognitive impairment, 10-17 indicates moderate cognitive impairment 
and <10 indicates severe cognitive impairment.  
c) Driving habits questionnaire (DHQ) 
The driving habits questionnaire (DHQ)[13] is also interviewer-administered. It addresses six 
domains: current driving status and driving practices (seatbelt use, driving speed, self-
assessment of quality of driving); driving exposure (average number of days driven per week, 
where the participant drives); dependence on other drivers (with whom the subject usually 
travels in a car); driving difficulty (how the subject drives in different driving situations); 
driving space (distance the subject typically drives); and self-reported accidents.[13] The 
DHQ‟s results are examined separately and cannot be used as a total score. The 
questionnaire‟s test-retest reliability is high[13] and it has been validated in previous studies 
investigating the driving habits of patients with chronic disease.[14–16] As the original 
questionnaire was designed for patients from America, minor modifications were made to 
make it suitable for UK participants (for example, using the word motorway instead of 
highway, turning right into oncoming traffic instead of left).  
Driving simulation 
A driving simulation was designed with the purpose of assessing reaction times. The 
hardware used was a standard computer with a graphics card on a 3440 X 1440 pixel, 34 
inches wide screen monitor (LG 34UM95-P). Driving feedback was provided through visual, 
auditory and kinetic channels. Sound intensity, provided through a speaker stereo system, 
varied with acceleration, braking and movement relative to the road. The driving interface 
was a T500RS force feedback steering wheel and three-pedal set (Thrustmaster, Hillsboro, 




United States). The interface provides a slight opposing force through the steering wheel as it 
is turned. 
The simulation was developed using the Unity game development platform and software 
language C# (Version 6.0, Redmond, United States). The programme allows the participant 
to accelerate in a simulated car up to 180 miles per hour (mph) or 288 kilometres per hour 
(kph), in a virtual environment consisting of a 3.5 km elliptical urban road with houses on 
both sides. On-screen visual features included pavements on either side as well as 25 road 
signs, 17 speed signs, 8 parked cars and 4 rubbish bins (Video 1). Houses, cars and other 
features used in the simulation were developed in 3D Studio Max (Version Autodesk 3ds 
Max 2016, Autodesk, Inc, Mill Vill, United States). All simulated features were developed 
from photographs of local features to imitate as closely as possible the local driving 
environment. There were no oncoming vehicles or pedestrians. Speed limit signs showed a 
mandatory 30 mph zone (the usual urban speed limit in the UK).  
 
Standardised instructions were given to each participant before the start of the simulation and 
at fixed points during the course. Participants were asked to complete three laps, identical in 
route, each lasting approximately 3 minutes. Participants were asked to drive as they would 
normally. No measurements were made for the first lap, which served as a “warm up” lap to 
allow the participant to get used to the controls, steering and braking systems. Measurements 
taken during the second lap were: the time taken to complete the lap (in seconds); mean speed 
(miles per hour); number of times the accelerator and brake were pressed; number of times 
the car drove off the road; and number of collisions with obstacles on the road or houses.  
 




During the third lap, a sign asking the participant to make an emergency stop (to simulate a 
hazard) appeared at five fixed points during the course (Figure 1; Video 1). Before starting 
the simulation, the participants were informed that hazards would appear requiring them to 
stop. The following additional measurements were additionally recorded by the computer 
system for each hazard: the speed at which the participant was travelling when the hazard 
appeared; the time taken from the appearance of the hazard to initiation of breaking (reaction 
time); the time taken from the appearance of the hazard to the vehicle coming to a stop 
(stopping time); and the time taken to press the accelerator again after stopping (restarting 
time). Reaction and stopping distances were calculated. 
   
Statistical analysis 
Descriptive statistics were used to characterize the demographics, prevalence of driving 
habits and driving simulation results in the HF and control groups. The independent t-test was 
used for continuous data (normality of distribution and homogeneity of variance), Fisher‟s 
exact test (less than five observations in each cell) or Pearson‟s chi-squared test (at least five 
observations in each cell) were used for nominal data and the Mann-Whitney U-test was used 
for non-parametric data to examine differences between patients and controls. Statistical 
analysis was performed using STATA version 14.2 (StataCorp, Texas, United States) and 
Excel version 2016 (Microsoft, Redmond, United States).  A p value of 5% was considered 
statistically significant. Continuous variables with a normal distribution will be displayed as 
mean and standard deviation (SD), whilst continuous variables with a non-parametric 
distribution will be displayed as median and interquartile range (IQR)  
  





Patient recruitment and characteristics 
The flow of patients through the study is shown in Figure 2. Of the 247 patients with HF 
approached, 216 (87%) were excluded, most commonly because they had already voluntarily 
stopped driving due to symptoms they attributed to heart failure (92 patients, 37%). Another 
quarter (60, 24%) of patients had never had a driving license. No patients had any medical 
devices in situ (Cardiac-resynchronisation therapy, implantable cardiac defibrillator or left 
ventricular assist device)  None were on long term oxygen therapy at home. 
Of the 74 controls who were approached, 46 declined to participate in the study with no 
reason given, and only one had voluntarily stopped driving for a medical condition. No 
participant in the control group cited never having a driving license as the reason for not 
driving.    
One participant from each group withdrew from the study – one in the HF group gave no 
reason, and one in the control group withdrew due to nausea during the driving simulation.  
Table 1 shows demographic data. Of the patients with HF, 77% had NYHA Class I or II 
symptoms. None was breathless at rest. Most had moderate or severe left ventricular systolic 
dysfunction; and only 2 had heart failure with normal ejection fraction. Patients in the control 
group were similar in age and sex distribution but had a lower prevalence of atrial fibrillation.  
There was no difference in the PHQ-9 and MoCA scores between HF participants and 
controls. Two patients and two controls had a MoCA score <26, but none had moderate 
cognitive impairment (<17). Three patients and one control had a PHQ-9 score suggestive of 
depression. Patients reported consuming less alcohol per week than controls.  




Driving Habits Questionnaire 
The results of the driving habits questionnaire are shown in table 2. There was no difference 
between the groups in driving habits and no one reported having had a car crash in the 
previous year. Those with HF who continued to drive seemed to drive just as often, and as 
geographically wide as those without HF.  
Simulation  
Table 3 shows the results from lap 2 and 3 of the simulation. There was no difference in the 
time taken to complete the lap (and hence the mean speed) between the two groups. There 
were no collisions in either group. A few participants in both groups had an average speed 
that exceeded the speed limit of 30mph, but there were no significant differences in the 
number between groups. 
Table 4 shows the variables measured during lap 3 of the simulation, when hazards appeared. 
The mean speed when hazards appeared was similar in the two groups, but patients with HF 
had slightly longer reaction times. Reaction times were significantly longer in patients with 
HF (by around 0.5-1.5 milliseconds) in all but the first hazard (Figure 3). Stopping times and 
stopping distances did not differ between groups. Amongst patients with HF, reaction times 
and stopping distances did not differ by NYHA classification. 
 
  






We found that many patients with HF stop driving by choice. Compared to age-matched 
controls, patients with HF who continue to drive took longer to react to a hazard that 
appeared suddenly during our driving simulation. This longer reaction time however did not 
translate into longer stopping distances.  Since the speed of travel did not differ between 
patients and controls, this may imply that the HF group were able to brake harder than the 
control group.  
Driving is a complex skill requiring intact visual, motor and cognitive functions. Cognitive 
deficits are common in patients with CHF[1,17–19], a long history of hypertension,[20] prior 
stroke, or cerebral hypoperfusion, due to  low cardiac output and hypotension, may lead to 
functional and structural brain alterations, which could in turn affect reaction time. Poor 
sleeping habits,[21] anxiety and depression[22] are also common in patients with HF and 
may further affect concentration a key component in safe driving. 
In a different driving simulation which lasted longer (30 minutes) and involved driving in a 
variety of environments, Alosco and colleagues found that poor physical fitness and reduced 
cognitive function secondary to HF were associated with more collisions and stop signs 
missed.[23] We deliberately set out to model the typical driving environment of older patients 
undertaking short trips in an urban environment that might mimic activities daily life (such as 
a trip to go shopping or visit friends) and found all patients in our study to be fit to drive. 
Although the simulation was well received, tests were conducted in a research environment. 
Driving simulator tasks are correlated with on-road performance,[24,25] but we cannot know 
how the performances on our specific simulation match actual driving abilities on the road. 




Therefore, our results require confirmation in further studies and should be interpreted with 
caution. There is no consensus on how to determine fitness to drive for patients with HF. 
Even in patients after ischaemic stroke, where is a large literature regarding driving, there is 
considerable variability in the results of cognitive, on-road and simulator-based 
assessments.[26] For most patients, neurocognitive testing combined with a road-test might 
be considered to be current best practise in determining safety to drive, although this would 
be a major undertaking if applied to patients with HF.[6] 
Interestingly, the majority of patients with HF whom we approached for the study had 
already stopped driving, confirming previous findings. In the ACTIVE trial,[27] HF was a 
significant risk factor for driving cessation amongst 1,656 older adults over a 5- year period. 
Sims and colleagues studied 5,383 community-dwelling drivers aged 65 years or over, and 
also found that HF was an independent risk factor for driving cessation.[28]  However, the 
decision for patients with HF to stop driving is complex, and external factors, such as 
pressure from close family members or changes in circumstances (e.g., occupation or 
retirement), are likely to have a significant influence.   
 
Limitations 
The sample size is small, but comparable to previous studies looking at driving in patients 
with chronic diseases.[14–16] Our study included only patients who drive at least once a 
week and the population is thus self-selecting. Consequently, our patients had relatively mild 
HF. Although our control group did not have HF, many had risk factors for cerebrovascular 
disease. This may limit the ability to find comparisons with the study group. Reaction times 
may have been different in elderly individuals completely free of cardiovascular disease, but 




such a „healthy‟ age-matched control group in the UK is rare. Similarly, reaction times may 
have been different in younger individuals with HF or those with a more sever degree of 
cognitive impairment. We did not formally assess the patients‟ visual fields, which has an 
impact on driving ability. Reaction times and stopping times may be different in patients who 
continue to drive with severe HF.  
This was a pilot study with simple outcome measurements. Our simulation was relatively 
straightforward, with good weather conditions and low speed. Future studies could focus on 
two things. Firstly it may be useful to investigate more complex traffic scenarios reflective of 
„real life‟, with higher road speeds, weather changes and increased visual clutter, all of which 
would increase demand on driving attention, assessed using more subtle measurements of 
driving function, such as deviation from the centre of the road whilst driving. Secondly, one 
could compare clinical and simulation differences between those with HF who drive and 
those who have stopped; this may create a blueprint of factors associated with driving 
cessation, and alert clinicians to certain qualities that may trigger fitness to driving 
evaluations, or a conversation for driving retirement in those outliers who may drive 
dangerously.  
Conclusion 
Older adults with HF who regularly drive have slightly longer reaction times than controls, 
but did not have any markers of dangerous driving in a driving simulation mimicking local 
driving.   
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Graphical abstract: Many patients with HF have already stopped driving. Patients with HF 
who continued to drive had slower reaction times on an urban driving simulation. However, 
this did not translate into any markers of dangerous driving.   





Figure 1: Photographs of the simulation during normal driving conditions (bottom panel) and 
when the emergency hazard appears (top, on the right). On the top left, a map shows the 
course for one lap, with „X‟s marking points where the hazards will appear during the third 
lad. The participant cannot see this map. 





Figure 2: Flowchart of participants through the study.  





Figure 3: Line charts illustrating the trend of reaction times and stopping distances between 
patients with chronic heart failure and controls. P values were calculated using the Kruskall-
Wallis test; * is a p value<0.05, ** is a p value<0.01.  
  





Video 1: A demonstration of the driving simulation. Hazards appeared in the third lap, 
requiring the participant to press the brakes until the vehicle comes to a stop.  
  





Variables CHF (N=30) Controls (N=26) P value 
Demographics 
Age (years) 74 ± 5 73±5 0.32 
Males – n.(%) 27 (90) 23 (88) 0.58 
Comorbidities    
Hypertension – n.(%) 14 (47) 15 (56) 0.11 
Ischaemic Heart Disease – n.(%) 11 (37) 15 (56) 0.42 
Myocardial Infarction – n.(%) 4 (13) 2 97) 0.18 
Type 2 Diabetes – n. (%) 9 (30) 6 (22) 0.25 
Stroke/Transient Ischaemic Attack – n. (%)  3 (10) 1 (4) 0.07 
Peripheral Vascular Disease – n. (%) 5 (17) 5 (19) 0.24 
Atrial Fibrillation – n. (%) 14 (47) 2 (7) 0.02 
Hyperlipidaemia – n. (%) 16 (53) 10 (37) 0.27 
COPD – n. (%) 4 (13) 2 (7) 0.18 
NYHA Class – n. (%)    
Class I 6 ( 20) - NA 
Class II 17 (57) - NA 
Class III 7 (23) - NA 
MoCA score  28.34 ± 1.71 28.53 ± 2.88 0.33 
MoCA score: 17- 26  2 (7) 2(8) 1.00 
PHQ-9 score  1 (0-3) 0 (0-1) 0.21 
PHQ-9 score ≥5 (number of people)  3 (10) 1 (4) 0.62 
Alcohol consumption units/week  1 (0 -3) 6 (0-16) 0.02 
Heart rate prior to simulation - bpm 69 (12) 68 (11) 0.66 
PR-interval on ECG  - ms 190(29) 164 (26) 0.01 
QRS duration on ECG - ms 108 (98-148) 88 (82-98) 0.001 














Blood tests  
NT-proBNP – ng/L  1510 (546-3084) 135 (73-182) 0.001 





Table 1: Characteristics of patients with chronic heart failure (HF) and controls 




















Do you wear glasses/contact lenses when 
driving?  
     Yes 











Do you wear seatbelt when driving?  
     Always 
     Sometimes 











Preferred method of transport 
Public transportation/taxi 




































Have been suggested to limit driving by family 
or friends  
     Yes 











  0.59 
Haemoglobin - g/L  135 (128-144) 141 (134-154) 0.17 
Creatinine - µmol/L  115 (100-139) 83 (69-103) 0.005 
Potassium - mmol/L  4.4 (4.1 – 4.6) 4.3 (4.0-4.6) 0.75 
Sodium - mmol/L  136 (135 – 138) 138 (137-140) 0.65 

















































If they had to go somewhere and didn‟t want to 
drive themselves, they would  
Ask a friend or relative to drive 
Call a taxi/take a bus 
Drive regardless of how they felt 



















Number of days per week a patient drives  6 (3-7) 6 (3-7) 0.74 
Number of places travelled to per week  3 (2-3 ) 3 (2-3) 0.75 
Number of total trips taken per week  7 (4-10) 5 (4-7) 0.13 
Total number of miles driven per week 79 (4-131) 62 (36-131) 0.58 








Total dependency score when travelling  1 (1-1) 1 (1-1) 0.88 
Rating of driving in the following 
circumstances*  
  Raining  
  Driving alone 
  Parallel parking  
  Right hand turns across oncoming traffic 
  Driven on motorways 
  High traffic roads 
  Driving in rush hour traffic 
































Number of accidents in the past year where they 







Number of accidents in past year when police 







Number of times in the past year where they 
have been pulled over by the police regardless 










Number of times in the past year where they 











During the past year, driven to  
   Immediate neighbourhood 
   Beyond immediate neighbourhood 
   Neighbouring cities 
   Distant towns/cities 

























Table 2: Results from the driving habits questionnaire. *For driving in certain circumstances, 
0 = No difficulty, 1 = Little difficulty, 2 = Moderately difficult, 3 = Extremely difficult  
 
Table 3: Summary of main findings from lap 2 and 3 







Time taken to complete lap in 
seconds  
244.7 (230.4-282.5) 248.9 (229.9-280.7) 0.84 
Mean speed/mph 25.9 (5.4)   25.2 (3.9) 0.59 
Number of patients‟ mean speed 
>30mph  
2 (7) 3 (12) 0.66 
Number of times accelerator was 
pressed 
9 (4-21) 10 (6-21) 0.69 
Number of times brakes were 
pressed 
0 (0-1) 0 (0-1) 0.65 
Number of times car hit the 
pavement  
0 (0-0) 0 (0-0) NA 
Collisions with obstacles or 
houses  
0 (0-0) 0 (0-0) NA 
Lap 3 
Time taken to complete lap in 
seconds  
287.0 (260.3-327.2) 286.5 (272.2-317.2) 0.77 
Mean speed/mph 22.0 (4.5) 21.7 (3.3) 0.80 
Number of patients‟ mean speed 
>30mph 
1 (3) 0 (0) 1.00 
Number of times accelerator was 
pressed  
19 (11-31) 19 (10-29) 0.78 
Number of times brakes were 
pressed  
6 (5-7) 6 (5-6) 0.57 
Number of times car hit the 
pavement  
0 (0-0) 0 (0-0) NA 
Collisions with obstacles or 
houses  
0 (0-0) 0 (0-0) NA 






Speed travelling when hazard appears/mph – 26.6 (5.6) 25.5 (3.6) 0.43 





Table 4: Summary of additional findings from lap 3, when hazards appeared  
 
mean (SD) 
Reaction time/seconds – median (IQR) 1.10 (0.98 – 1.30) 0.96 (0.83-1.10) 0.02 
Stopping time/seconds – median (IQR) 3.46 (3.07-4.05) 3.25 (2.98-3.88) 0.23 
Stopping distance/metres – median (IQR) 43.9 (32.2-49.5) 38.1 (32.3-48.8) 0.31 
Restarting time/seconds – median (IQR) 2.29 (1.48-3.55) 1.65 (1.38-2.57) 0.08 
Restarting distance/metres – median (IQR) 12.0 (10.1-18.5) 11.2 (9.5-13.2) 0.13 
